Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
Contact

Poster – Automated Segmentation of MS Brain Lesions

  • Category: Published research
  • Product: NeuroQuant MS
  • Disease: Multiple sclerosis

Cortechs.ai was pleased to have this UC San Diego School of Medicine poster presented at ACTRIMS Forum 2018

Automated quantitative measures from MRI, such as lesion volume and distribution, have significant value for clinicians evaluating disease progression. Clinical standards for lesion evaluation include visual inspection of MRI images, or expert manual segmentation of lesions. These subjective measurements lack standardization and reproducibility in clinical settings

Cortechs.ai’ LesionQuant module is a fully-automated lesion segmentation tool for clinical use designed to provide accurate and reproducible lesion segmentations. This study demonstrates that automated segmentation of MS lesion volumes and counts by LesionQuant provides reproducible results that correlate well with expert manual counts and analysis.

For more information about LesionQuant or this poster, contact us. Click image below to view in pdf.

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions

  • Topic: Published research

More Resources

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
  • 6 mins

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
  • 5 mins

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
  • 2 mins

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
  • 3 mins

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
  • < 1 mins

07/28/2025

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

A case study with Dr. Suzie Bash on NeuroQuant as a reliable, reimbursable, and efficient tool in the evaluation and follow-up of TBI.

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
  • 3 mins

07/24/2025

Understanding the Hippocampal Occupancy Score

One of the most frequently asked questions among customers is, “What does the Hippocampal Occupancy Score (HOC) represent within the Dementia Report?”

View our insights
Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Poster – Automated Segmentation of MS Brain Lesions
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top